Decibel Announces Timing of Annual Meeting of Shareholders and New Director Nominees
Ryan Allway November 21st, 2022 News, Top News CALGARY, AB, Nov. 21, 2022 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), announces the timing of its annual general meeting (the “Meeting”) of holders of common shares (the “Shareholders”) of the Company will be held at 4:00pm (Calgary... Read more
Flora Growth Sets Third Quarter 2022 Conference Call for November 28, 2022, at 4:30 P.M. ET
Ryan Allway November 21st, 2022 News, Top News FORT LAUDERDALE, Fla. & TORONTO, November 21, 2022–(BUSINESS WIRE)–Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, will host its third quarter 2022 earnings call via webcast on Monday,... Read more
Grapefruit USA, Inc. Provides Further Update on Diagnostic Lab Corporation, Inc. Acquisition, Securing New Financing
Ryan Allway November 21st, 2022 News, Top News LOS ANGELES and DESERT HOT SPRINGS, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, is updating its recent announcement of the proposed acquisition of Diagnostic... Read more
Tilray Brands, Inc. (TLRY) Launches ‘Take Back Control’ Platform to Provide Women With Free Medical Cannabis
Evogene (EVGN) Reports Q3 Loss, Tops Revenue Estimates
Ryan Allway November 17th, 2022 News, Top News Thu, November 17, 2022 – Evogene (EVGN) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.19 per share a year ago. These figures are... Read more
MyMD Pharmaceuticals® Announces Upcoming Presentation of Late-Breaking Data for MYMD-1® at the 2022 British Society for Immunology (BSI) Congress
Ryan Allway November 17th, 2022 News, Top News – Preclinical and early clinical studies of MYMD-1®, an oral, small-molecule, selective TNF-α inhibitor accepted for presentation – BALTIMORE, November 17, 2022–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company developing groundbreaking therapies for the treatment of serious... Read more
Xebra Provides Update on the Issuance of its Mexican Cannabis Authorizations
Ryan Allway November 17th, 2022 News, Top News VANCOUVER, BC, Nov. 17, 2022 /PRNewswire/ – Xebra Brands Ltd. (“Xebra”) (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC), a cannabis company, provides an update on the issuance of its Mexican cannabis authorizations. Xebra Brands Ltd. (CNW Group/Xebra Brands Ltd.) Xebra previously announced that it expected the... Read more
Clearmind Medicine Announces Closing of US$7.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
Ryan Allway November 17th, 2022 News, Top News VANCOUVER, Nov. 17, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq and CSE: CMND), (FSE: CWY) (“Clearmind” or the “Company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced the closing of... Read more
Evogene Reports Third Quarter 2022 Financial Results
Ryan Allway November 17th, 2022 News, Top News Conference call and webcast: today, November 17, 2022, 9:00 am ET REHOVOT, Israel, Nov. 17, 2022 /PRNewswire/ — Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science based product discovery and development utilizing cutting edge computational biology technologies, across multiple... Read more
TILT Holdings Inc. (TLLTF) Subsidiary Jupiter Research Enters Into Agreement with House of Blends Inc.
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )